BERKELEY, Calif. and MAINZ, Germany - Mainz Biomed NV (NASDAQ:MYNZ), a company focused on early cancer detection diagnostics, has announced its return to compliance with Nasdaq's stockholders' equity ...

York-based Abingdon Health PLC has received EUR800,000 (£672,000) to develop malaria tests. The diagnostic test kit company is among several institutes to receive grant money from UK Research & ...